Search

Author/Creator Gill, Sanjeev

1. Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer. (1st April 2019)

Authors:
Vasista, Anuradha; Stockler, Martin; Martin, Andrew; Pavlakis, Nick; Sjoquist, Katrin; Goldstein, David; Gill, Sanjeev; Jain, Vikram; Liu, Geoffrey; Kannourakis, George; Kim, Yeul Hong; Nott, Louise; Snow, Stephanie; Burge, Matthew; Harris, Dean; Jonker, Derek; Chua, Yu Jo; Epstein, Richard; Bona...
Journal:
Oncologist
Issue:
Volume 24:Number 11(2019)
Page Start:
e1102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. Issue 6 (June 2021)

Authors:
van den Bent, Martin J; Tesileanu, C Mircea S; Wick, Wolfgang; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M; Erridge, Sarah; Vogelbaum, Michael A; Nowak, Anna K; Baurain, Jean Français; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Taa...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 6(2021)
Page Start:
813
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study. (October 2022)

Authors:
Dean, Andrew; Gill, Sanjeev; McGregor, Mark; Broadbridge, Vy; Järveläinen, Harri A; Price, Timothy
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 10(2022)
Page Start:
943
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Issue 10103 (7th October 2017)

Authors:
van den Bent, Martin J; Baumert, Brigitta; Erridge, Sara C; Vogelbaum, Michael A; Nowak, Anna K; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M; Baurain, Jean Francais; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Brachman, David G; Taal, Walter; Rudà,...
Journal:
Lancet
Issue:
Volume 390:Issue 10103(2017)
Page Start:
1645
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Issue 9 (29th April 2021)

Authors:
Tesileanu, C Mircea S; van den Bent, Martin J; Sanson, Marc; Wick, Wolfgang; Brandes, Alba A; Clement, Paul M; Erridge, Sara C; Vogelbaum, Michael A; Nowak, Anna K; Baurain, Jean F; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Taal, Walter; ...
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 9(2021)
Page Start:
1547
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗